Irene Paula Popa
Overview
Explore the profile of Irene Paula Popa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Popa S, Sarbu I, Bulgaru-Iliescu D, Surd A, Candussi I, Popa I, et al.
J Family Med Prim Care
. 2024 Dec;
13(11):4994-5001.
PMID: 39723007
Background: Fractures occurring in the lower extremities as a result of road traffic accidents (RTAs) can lead to considerable morbidity and constitute a large proportion of nonfatal injuries that necessitate...
2.
Clim A, Maranduca M, Filip N, Tanase D, Floria M, Pinzariu A, et al.
Life (Basel)
. 2024 Nov;
14(11).
PMID: 39598213
Objective: In our experimental study, we evaluated the influence of treatment with atorvastatin on the antioxidant activity of intracellular and extracellular systems factors, homocysteine levels (Hcy), and lipid profiles in...
3.
Popa I, Clim A, Pinzariu A, Lazar C, Popa S, Tudorancea I, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407987
Arterial hypertension (HTN) is one of the major global contributors to cardiovascular diseases and premature mortality, particularly due to its impact on vital organs and the coexistence of various comorbidities...
4.
Maranduca M, Cozma C, Clim A, Pinzariu A, Tudorancea I, Popa I, et al.
Curr Issues Mol Biol
. 2024 May;
46(5):3877-3905.
PMID: 38785509
Chronic kidney disease (CKD) stands as a prominent non-communicable ailment, significantly impacting life expectancy. Physiopathology stands mainly upon the triangle represented by parathormone-Vitamin D-Fibroblast Growth Factor-23. Parathormone (PTH), the key...
5.
Popa S, Bulgaru-Iliescu D, Ciongradi C, Surd A, Candussi I, Popa I, et al.
Children (Basel)
. 2024 Apr;
11(4).
PMID: 38671642
Background: By 2025, road traffic injuries are projected to rank third in the global burden of disease, posing a significant challenge that affects health, social well-being, and economic aspects. According...
6.
Popa S, Sarbu I, Ciongradi C, Popa I, Bulgaru-Iliescu D
Children (Basel)
. 2023 Sep;
10(9).
PMID: 37761486
Background: Pediatric road traffic accidents (RTAs) have a substantial impact on the worldwide youth population, resulting in a considerable burden of disability. According to the World Health Organization's (WHO) Global...
7.
Popa S, Ciongradi C, Sarbu I, Bica O, Popa I, Bulgaru-Iliescu D
Children (Basel)
. 2023 Sep;
10(9).
PMID: 37761407
Traffic accidents involving children and adolescents present complex challenges from both the medico-legal and orthopedic standpoints. Despite the implementation of road traffic safety laws, pediatric road traffic injuries continue to...
8.
Popa I, Serban D, Maranduca M, Serban I, Tamba B, Tudorancea I
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36834739
Brugada syndrome (BrS) is a rare hereditary arrhythmia disorder, with a distinctive ECG pattern, correlated with an increased risk of ventricular arrhythmias and sudden cardiac death (SCD) in young adults....
9.
Haba M, Tudorancea I, Miftode R, Popa I, Mitu O, Mihai C, et al.
J Pers Med
. 2022 Dec;
12(12).
PMID: 36556304
(1) Background: Pulmonary embolism (PE) represents the third most important cardiovascular cause of death after myocardial infarction and stroke. The proper management of this condition is dependent on adequate risk...
10.
Popa I, Haba M, Maranduca M, Tanase D, Serban D, Serban L, et al.
Pharmaceutics
. 2022 Sep;
14(9).
PMID: 36145711
Heart failure (HF) is a progressively deteriorating medical condition that significantly reduces both the patients' life expectancy and quality of life. Even though real progress was made in the past...